How PFAS "Forever Chemicals" in Drinking Water Cause Cancer and Disease
Per- and polyfluoroalkyl substances (PFAS) are a class of synthetic fluorinated chemicals used in industrial processes, consumer products, and aqueous film-forming foam (AFFF) firefighting foam since the 1940s. Because the carbon-fluorine bond is one of the strongest in chemistry, PFAS do not break down in the environment or the human body — earning them the name "forever chemicals." When PFAS enter drinking water through industrial discharge, AFFF runoff, or contaminated groundwater, communities face decades of exposure through their tap water. Chronic ingestion causes progressive bioaccumulation in blood, liver, and kidneys, triggering a cascade of toxic mechanisms that have been linked to kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, pregnancy-induced hypertension, and immunosuppression.
Serum Protein Binding and Organ Bioaccumulation
PFOA and PFOS bind tightly to serum albumin and liver fatty acid-binding proteins, concentrating in the liver, kidney, and blood. Unlike most environmental toxicants that are excreted within days, PFOA has a half-life of approximately 3.5 years in human serum and PFOS approximately 5 years. This means even modest ongoing exposure through contaminated drinking water results in steadily increasing body burdens over years and decades — with no biological mechanism for clearance unless exposure ceases entirely.
Endocrine Disruption and Thyroid Hormone Interference
PFAS structurally mimic thyroid hormones and compete with them for binding sites on serum transport proteins, particularly transthyretin. This interference suppresses free T4 and T3 levels, alters thyroid-stimulating hormone feedback, and disrupts the hypothalamic-pituitary-thyroid axis. Epidemiological studies of contaminated communities — including the C8 Health Project in Parkersburg, West Virginia — found significantly elevated rates of thyroid disease among residents with high PFOA serum levels. The C8 Science Panel found a probable link between PFOA exposure and thyroid disease.
Immune System Suppression and Reduced Vaccine Response
PFAS exposure is associated with dose-dependent suppression of antibody production following vaccination. Studies of Faroese children — a cohort with high seafood-related PFAS exposure — found that each doubling of PFAS serum concentration was associated with a 25–50% reduction in vaccine antibody titers against diphtheria and tetanus. Similar findings have been replicated in adult cohorts. The mechanism involves PFAS interference with B-cell and T-cell signaling pathways. In 2022, the National Toxicology Program concluded that PFAS are an immune hazard to humans.
Carcinogenicity — Kidney and Testicular Cancer
PFOA was classified as a Group 1 carcinogen (carcinogenic to humans) by the International Agency for Research on Cancer in November 2023, based on sufficient evidence from human epidemiology. The C8 Science Panel established probable links between PFOA exposure and kidney cancer and testicular cancer in the Mid-Ohio Valley population. PFOA promotes tumor formation through multiple pathways including PPAR-alpha activation (liver), oxidative stress, DNA damage response inhibition, and suppression of tumor suppressor gene expression. These mechanisms are dose-dependent and consistent across multiple epidemiological cohorts.
Developmental Toxicity and In Utero Exposure
PFAS cross the placental barrier and accumulate in umbilical cord blood and breast milk, exposing fetuses and newborns to maternal body burdens accumulated over years. In utero PFAS exposure has been associated with reduced birth weight, altered immune development, accelerated puberty in girls, and neurodevelopmental effects. Animal studies demonstrate fetal lethality, growth retardation, and skeletal deformities at high doses. The developing endocrine and immune systems are particularly vulnerable to disruption during critical windows of fetal development when PFAS cannot be cleared.
- Invisible Contamination — No Taste, No Odor: PFAS are odorless, colorless, and tasteless in water at concentrations far exceeding health thresholds. Communities in Parkersburg, West Virginia and Camp Lejeune, North Carolina consumed PFAS-contaminated water for decades without any sensory indication of contamination. Without systematic testing, residents have no means of detecting exposure. This invisibility meant that affected populations could not take protective action and continued to accumulate body burdens unknowingly.
- Decades-Long Latency Before Diagnosis: Cancers linked to PFAS exposure — including kidney cancer and testicular cancer — typically have latency periods of 10 to 30 years from initial exposure to clinical diagnosis. This means residents exposed through contaminated municipal water in the 1980s and 1990s may only now be manifesting PFAS-related cancers. The long latency makes it difficult for individuals to connect their cancer to water contamination years or decades earlier, and complicates statute of limitations analysis.
- Universal Exposure Through Drinking Water Infrastructure: Unlike occupational PFAS exposures limited to workers, contaminated municipal water systems expose entire communities — men, women, children, and infants — through drinking, cooking, bathing, and food preparation. EPA estimates that PFAS are detectable in drinking water serving over 200 million Americans. Populations near military bases, airports, and PFAS manufacturing facilities face the highest concentrations, but PFAS contamination has been detected in water systems across all 50 states.
- Manufacturer Knowledge Predating Community Exposure: 3M's internal toxicology studies from 1975 documented that PFOS caused significant toxicity in animal models. DuPont's internal records from the 1960s acknowledged that C8 (PFOA) was toxic and bioaccumulative. Both companies continued manufacturing and selling PFAS products for decades without warning communities, regulators, or the public. The gap between manufacturers' internal knowledge and public disclosure — in some cases exceeding 30 years — is central to the mass tort claims.
- The International Agency for Research on Cancer classified PFOA as a Group 1 carcinogen in November 2023, the highest classification indicating sufficient evidence of human carcinogenicity.
- The C8 Science Panel — an independent panel of epidemiologists funded by DuPont's settlement — found probable links between PFOA exposure and kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, and pregnancy-induced hypertension.
- The National Toxicology Program concluded in 2022 that PFAS are an immune hazard to humans based on consistent evidence of suppressed vaccine antibody responses across multiple study populations.
- The EPA finalized Maximum Contaminant Levels of 4 parts per trillion for PFOA and PFOS individually in April 2024 — acknowledging no safe level of exposure — after decades of less protective health advisories.
- Multiple large epidemiological studies have demonstrated dose-response relationships between PFAS serum concentrations and cancer incidence, immune dysfunction, and thyroid disruption, supporting biological plausibility of causation.
The harm mechanisms established by the C8 Science Panel, IARC, NTP, and independent epidemiologists provide the scientific foundation for PFAS water contamination litigation. Plaintiffs diagnosed with kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, or pregnancy-induced hypertension who consumed contaminated drinking water can establish general causation through the C8 probable link findings and IARC's Group 1 classification. Specific causation requires evidence of PFAS exposure through contaminated water systems and, where possible, serum PFAS testing to document body burden.